APA (7th ed.) Citation

Prasad, M., Zorea, J., Jagadeeshan, S., Shnerb, A. B., Mathukkada, S., Bouaoud, J., . . . Elkabets, M. (2022). MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer. Journal for ImmunoTherapy of Cancer, 10(3), . https://doi.org/10.1136/jitc-2021-003917

Chicago Style (17th ed.) Citation

Prasad, Manu, et al. "MEK1/2 Inhibition Transiently Alters the Tumor Immune Microenvironment to Enhance Immunotherapy Efficacy Against Head and Neck Cancer." Journal for ImmunoTherapy of Cancer 10, no. 3 (2022). https://doi.org/10.1136/jitc-2021-003917.

MLA (9th ed.) Citation

Prasad, Manu, et al. "MEK1/2 Inhibition Transiently Alters the Tumor Immune Microenvironment to Enhance Immunotherapy Efficacy Against Head and Neck Cancer." Journal for ImmunoTherapy of Cancer, vol. 10, no. 3, 2022, https://doi.org/10.1136/jitc-2021-003917.